107 related articles for article (PubMed ID: 16821800)
1. Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.
Pryde DC; Maw GN; Planken S; Platts MY; Sanderson V; Corless M; Stobie A; Barber CG; Russell R; Foster L; Barker L; Wayman C; Van Der Graaf P; Stacey P; Morren D; Kohl C; Beaumont K; Coggon S; Tute M
J Med Chem; 2006 Jul; 49(14):4409-24. PubMed ID: 16821800
[TBL] [Abstract][Full Text] [Related]
2. The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramides.
Maw GN; Stobie A; Planken S; Pryde DC; Sanderson V; Platts MY; Corless M; Stacey P; Wayman C; Van Der Graaf P; Kohl C; Coggon S; Beaumont K
Chem Biol Drug Des; 2006 Jan; 67(1):74-7. PubMed ID: 16492151
[TBL] [Abstract][Full Text] [Related]
3. Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder.
Pryde DC; Cook AS; Burring DJ; Jones LH; Foll S; Platts MY; Sanderson V; Corless M; Stobie A; Middleton DS; Foster L; Barker L; Van Der Graaf P; Stacey P; Kohl C; Coggon S; Beaumont K
Bioorg Med Chem; 2007 Jan; 15(1):142-59. PubMed ID: 17070062
[TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?
Angulo J
Br J Pharmacol; 2010 May; 160(1):48-50. PubMed ID: 20412067
[TBL] [Abstract][Full Text] [Related]
5. UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit.
Wayman CP; Baxter D; Turner L; Van Der Graaf PH; Naylor AM
Br J Pharmacol; 2010 May; 160(1):51-9. PubMed ID: 20412068
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor.
Kane BE; Grant MK; El-Fakahany EE; Ferguson DM
Bioorg Med Chem; 2008 Feb; 16(3):1376-92. PubMed ID: 17977730
[TBL] [Abstract][Full Text] [Related]
7. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors.
Zhao H; Serby MD; Xin Z; Szczepankiewicz BG; Liu M; Kosogof C; Liu B; Nelson LT; Johnson EF; Wang S; Pederson T; Gum RJ; Clampit JE; Haasch DL; Abad-Zapatero C; Fry EH; Rondinone C; Trevillyan JM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4455-8. PubMed ID: 16854050
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
[TBL] [Abstract][Full Text] [Related]
10. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor.
Tran JA; Jiang W; Tucci FC; Fleck BA; Wen J; Sai Y; Madan A; Chen TK; Markison S; Foster AC; Hoare SR; Marks D; Harman J; Chen CW; Arellano M; Marinkovic D; Bozigian H; Saunders J; Chen C
J Med Chem; 2007 Dec; 50(25):6356-66. PubMed ID: 17994683
[TBL] [Abstract][Full Text] [Related]
12. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women.
Middleton LS; Kuffel SW; Heiman JR
Arch Sex Behav; 2008 Dec; 37(6):950-61. PubMed ID: 18256919
[TBL] [Abstract][Full Text] [Related]
13. Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysis.
Meng X; Maggs JL; Pryde DC; Planken S; Jenkins RE; Peakman TM; Beaumont K; Kohl C; Park BK; Stachulski AV
J Med Chem; 2007 Nov; 50(24):6165-76. PubMed ID: 17985860
[TBL] [Abstract][Full Text] [Related]
14. Pyridine-3-carboxamides as novel CB(2) agonists for analgesia.
Mitchell WL; Giblin GM; Naylor A; Eatherton AJ; Slingsby BP; Rawlings AD; Jandu KS; Haslam CP; Brown AJ; Goldsmith P; Clayton NM; Wilson AW; Chessell IP; Green RH; Whittington AR; Wall ID
Bioorg Med Chem Lett; 2009 Jan; 19(1):259-63. PubMed ID: 19010671
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
18. Influence of PDE5 inhibitor on MRI measurement of clitoral volume response in women with FSAD: a feasibility study of a potential technique for evaluating drug response.
Yang CC; Cao YY; Guan QY; Heiman JR; Kuffel SW; Peterson BT; Maravilla KR
Int J Impot Res; 2008; 20(1):105-10. PubMed ID: 18059502
[TBL] [Abstract][Full Text] [Related]
19. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
[TBL] [Abstract][Full Text] [Related]
20. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
